No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
DSS DSS Inc
- 1.7550
- -0.0450-2.50%
Close Apr 25 16:00 ET
- 1.7900
- +0.0350+1.99%
Post 18:50 ET
12.40MMarket Cap-152P/E (TTM)
1.8400High1.7400Low6.76KVolume1.8400Open1.8000Pre Close12.00KTurnover0.24%Turnover RatioLossP/E (Static)7.07MShares9.360052wk High0.19P/B5.05MFloat Cap1.645052wk Low--Dividend TTM2.87MShs Float331917.1514Historical High--Div YieldTTM5.56%Amplitude1.6450Historical Low1.7740Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
DSS and PRPL Among Consumer Discretionary Movers
Express News | Impact Biomedical Announces U.S. Patent Allowance Of Laetose Technology Titled "Low Glycemic Sugar Composition"
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose Technology Entitled "Low Glycemic Sugar Composition."
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE:DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose technology
QuantumScape, Peloton Interactive, WW International Among Consumer Discretionary Movers
DSS, Inc. Chairman Chan Acquires 672,173 Shares of DSS In Open Market
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS, "Company")), a multinational company operating across four distinct market sectors, announced today a significant investment by its Chairman of the
12 Industrials Stocks Moving In Wednesday's After-Market Session
GainersRoyalty Management Hldgs (NASDAQ:RMCO) stock increased by 6.1% to $1.92 during Wednesday's after-market session. The company's market cap stands at $27.3 million. Mesa Air Gr (NASDAQ:MESA) shar
Comments
$DSS Inc(DSS.US$ I know some have suggested that the SEC will do nothing about this. I think it might be a good idea to call the Ombudsman of the SEC, Stacey Puente at her direct number which is 202-551-3330.
$Alset(40V.SG$$DSS Inc(DSS.US$
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
https://www.globenewswire.com/en/news-release/2023/11/28/2786916/0/en/Premier-Packaging-a-Wholly-Owned-Subsidiary-of-DSS-Inc-Secures-Contract-Extension-with-Major-Retailer-Worth-Up-to-15-Million-over-Four-Years.html
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
https://www.globenewswire.com/en/news-release/2023/11/28/2786916/0/en/Premier-Packaging-a-Wholly-Owned-Subsidiary-of-DSS-Inc-Secures-Contract-Extension-with-Major-Retailer-Worth-Up-to-15-Million-over-Four-Years.html
CEO of DSS, Inc., Frank Heuszel, values the conversion of DBH's equity interest into preferred stock, benefiting Impact's existing shareholders and DSS shareholders who obtained Impact shares via a dividend distribution.
1
$Alset(40V.SG$$DSS Inc(DSS.US$$Alset(AEI.US$
Biomedical technology developer Impact BioMedical files for a $15 million IPO
https://www.renaissancecapital.com/IPO-Center/News/101440/Biomedical-technology-developer-Impact-BioMedical-files-for-a-$15-million-I
Biomedical technology developer Impact BioMedical files for a $15 million IPO
https://www.renaissancecapital.com/IPO-Center/News/101440/Biomedical-technology-developer-Impact-BioMedical-files-for-a-$15-million-I
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg